publication venue for
- NCoA3 upregulation in breast cancer‑associated adipocytes elicits an inflammatory profile.. 49. 2023
- Osteosarcoma growth suppression by riluzole delivery via iron oxide nanocage in nude mice.. 43. 2019
- Sinomenine hydrochloride sensitizes cervical cancer cells to ionizing radiation by impairing DNA damage response.. 40. 2018
- In vitro long-term treatment with MAPK inhibitors induces melanoma cells with resistance plasticity to inhibitors while retaining sensitivity to CD8 T cells.. 37. 2017
- H19 lncRNA mediates 17β-estradiol-induced cell proliferation in MCF-7 breast cancer cells.. 33. 2015
- Epidermal growth factor receptor and KRAS mutations in lung adenocarcinoma: a retrospective study of the Lebanese population.. 32. 2014
- Hypoxia-targeted triple suicide gene therapy radiosensitizes human colorectal cancer cells.. 32. 2014
- Estrogen receptor-β expression and pharmacological targeting in bladder cancer.. 30. 2013
- Core binding factor acute myeloid leukaemia and c-KIT mutations.. 29. 2013
- Novel microtubule-targeting agents, pyrrolo-1,5-benzoxazepines, induce cell cycle arrest and apoptosis in prostate cancer cells.. 24. 2010
- Loss of ERα and FOXA1 expression in a progression model of luminal type breast cancer: insights from PyMT transgenic mouse model.. 24. 2010
- A phase II clinical trial of gemcitabine and split dose cisplatin in advanced non-small cell lung cancer in an outpatient setting.. 20. 2008
- Inhibition of tumor growth and tumor metastasis by a Chinese herbal formula--ZYD88, in an animal model with metastatic Lewis lung carcinoma.. 17. 2007
- The Chinese medicinal herbal formula ZYD88 inhibits cell growth and promotes cell apoptosis in prostatic tumor cells.. 10. 2003
- Combination chemotherapy using vincristine, adriamycin, cyclophosphamide (VAC) alternating with ifosfamide and etoposide (IE) for advanced soft tissue sarcomas: a phase II study.. 5. 1998
- Effects of tubulin-inhibiting agents in human lung and breast cancer cell lines with different multidrug resistance phenotypes.. 5. 1998
- Chronic myeloid leukemia treated with busulfan.. 3. 1996
- Fluorescence in situ hybridization (FISH) for evaluating residual disease in Philadelphia chromosome-positive chronic myeloid leukemia during interferon alpha therapy.. 3. 1996
- Acute hypertensive crisis following octreotide administration in a patient with malignant pheochromocytoma.. 2. 1995
- Potentially life‑threatening severe cutaneous adverse reactions associated with tyrosine kinase inhibitors (Review). 2020